Croda International Plc, a specialty chemical company providing high purity and high quality excipients for drug and vaccine development, has recently strengthened their offering with the acquisition of a line of vaccine adjuvants. Providing customers with over 80 years of adjuvant expertise, Croda Vaccine Adjuvants (formerly Brenntag Biosector) has unprecedented industry experience as a vaccine adjuvant specialist. In addition to supplying industry renowned aluminium- and saponin-based adjuvants, including the well-known brands Alhydrogel®, Adju-Phos® and Quil-A®, Croda is committed to developing the next generation of adjuvant technology, with a robust innovation pipeline focusing on enhanced protein binding and immune-stimulating nanotechnology.
Products & Services
Documents & Links
Adju-Phos®Adju-Phos is a range of aluminium phosphate gel products which have been specifically developed for use as an adjuvant in vaccines.
Alhydrogel®Alhydrogel is a range of aluminium hydroxide gel products which have been specifically developed for use as an adjuvant in human and veterinary vaccines.
QS-21A specific fraction of the saponin-based adjuvant Quil A®, QS-21 is an extremely potent adjuvant with potential use in a broad variety of vaccines.
Quil-A®Quil-A is a saponin adjuvant derived from the Quillaja saponaria Molina tree which has been specifically developed for use as an adjuvant in vaccines.
Vaccine Adjuvant Publication AbstractsCroda’s history and expertise in the vaccine industry is demonstrated by our collaboration on many published articles in reputable scientific journals.